Cargando…

Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients

Detalles Bibliográficos
Autores principales: Benning, Louise, Morath, Christian, Bartenschlager, Marie, Reineke, Marvin, Töllner, Maximilian, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Schaier, Matthias, Schnitzler, Paul, Zeier, Martin, Süsal, Caner, Bartenschlager, Ralf, Speer, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695512/
https://www.ncbi.nlm.nih.gov/pubmed/34954213
http://dx.doi.org/10.1016/j.kint.2021.12.009
_version_ 1784619595488821248
author Benning, Louise
Morath, Christian
Bartenschlager, Marie
Reineke, Marvin
Töllner, Maximilian
Nusshag, Christian
Kälble, Florian
Reichel, Paula
Schaier, Matthias
Schnitzler, Paul
Zeier, Martin
Süsal, Caner
Bartenschlager, Ralf
Speer, Claudius
author_facet Benning, Louise
Morath, Christian
Bartenschlager, Marie
Reineke, Marvin
Töllner, Maximilian
Nusshag, Christian
Kälble, Florian
Reichel, Paula
Schaier, Matthias
Schnitzler, Paul
Zeier, Martin
Süsal, Caner
Bartenschlager, Ralf
Speer, Claudius
author_sort Benning, Louise
collection PubMed
description
format Online
Article
Text
id pubmed-8695512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86955122021-12-23 Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients Benning, Louise Morath, Christian Bartenschlager, Marie Reineke, Marvin Töllner, Maximilian Nusshag, Christian Kälble, Florian Reichel, Paula Schaier, Matthias Schnitzler, Paul Zeier, Martin Süsal, Caner Bartenschlager, Ralf Speer, Claudius Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-03 2021-12-23 /pmc/articles/PMC8695512/ /pubmed/34954213 http://dx.doi.org/10.1016/j.kint.2021.12.009 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Benning, Louise
Morath, Christian
Bartenschlager, Marie
Reineke, Marvin
Töllner, Maximilian
Nusshag, Christian
Kälble, Florian
Reichel, Paula
Schaier, Matthias
Schnitzler, Paul
Zeier, Martin
Süsal, Caner
Bartenschlager, Ralf
Speer, Claudius
Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title_full Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title_fullStr Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title_full_unstemmed Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title_short Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
title_sort natural sars-cov-2 infection results in higher neutralization response against variants of concern compared with 2-dose bnt162b2 vaccination in kidney transplant recipients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695512/
https://www.ncbi.nlm.nih.gov/pubmed/34954213
http://dx.doi.org/10.1016/j.kint.2021.12.009
work_keys_str_mv AT benninglouise naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT morathchristian naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT bartenschlagermarie naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT reinekemarvin naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT tollnermaximilian naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT nusshagchristian naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT kalbleflorian naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT reichelpaula naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT schaiermatthias naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT schnitzlerpaul naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT zeiermartin naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT susalcaner naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT bartenschlagerralf naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients
AT speerclaudius naturalsarscov2infectionresultsinhigherneutralizationresponseagainstvariantsofconcerncomparedwith2dosebnt162b2vaccinationinkidneytransplantrecipients